Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMDA Amedica (AMDA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrends About Amedica Stock (NASDAQ:AMDA) 30 days 90 days 365 days Advanced Chart Ad InvestorPlaceWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. Get Amedica alerts:Sign Up Key Stats Today's Range$3.75▼$4.3050-Day Range$0.09▼$2.1952-Week Range$0.18▼$6.40Volume710,262 shsAverage Volume1.07 million shsMarket Capitalization$51.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.Read More… What Comes Next Could Be a Once-in-a-Lifetime Opportunity (Ad)A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.Click here now to watch the full briefing and discover the steps to take today. Receive AMDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amedica and its competitors with MarketBeat's FREE daily newsletter. Email Address AMDA Stock News HeadlinesSINTX Technologies (SINT)September 13, 2024 | es.investing.comHere's the Best Way for Investors to Play the IPO MarketNovember 5, 2023 | thestreet.comWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.November 22, 2024 | InvestorPlace (Ad)Silicon nitride ceramics Market 2022 | reach USD 683.74 million by 2028 - GlobeNewswireOctober 7, 2022 | globenewswire.comGlobal Interlaminar Device Market to Witness Growth by a CAGR of ~5% throughout 2022 – 2031 Owing to the - BenzingaMarch 27, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 20 - BenzingaFebruary 9, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 2021 to $4.9 Billion by 2026 - GlobeNewswireFebruary 9, 2022 | globenewswire.comSINTX TECHNOLOGIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.comNovember 12, 2021 | marketscreener.comSee More Headlines AMDA Stock Analysis - Frequently Asked Questions How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) issued its earnings results on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share for the quarter, topping the consensus estimate of ($0.94) by $0.01. The medical equipment provider earned $2.96 million during the quarter. Amedica had a negative trailing twelve-month return on equity of 148.60% and a negative net margin of 139.62%. When did Amedica's stock split? Amedica shares reverse split before market open on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Amedica own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), Net Element (NETE), Pernix Therapeutics (PTX), Synergy Pharmaceuticals (SGYP), Anavex Life Sciences (AVXL) and General Electric (GE). Company Calendar Last Earnings11/21/2017Today11/21/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:AMDA CUSIPN/A CIK1269026 Webwww.amedica.com Phone(855) 839-3500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,320,000.00 Net Margins-139.62% Pretax MarginN/A Return on Equity-148.60% Return on Assets-67.83% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99 Sales & Book Value Annual Sales$11.23 million Price / Sales3.93 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / Book2.07Miscellaneous Outstanding Shares11,870,000Free FloatN/AMarket Cap$44.16 million OptionableNot Optionable Beta-1.24 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report This page (NASDAQ:AMDA) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.